Company profile

Carpl.ai

Medical Imaging & Radiology

Company profile

About Carpl.ai

CARPL.ai operates an enterprise-grade radiology AI platform that simplifies the discovery, validation, and deployment of artificial intelligence solutions across healthcare institutions. The company provides a comprehensive marketplace featuring over 275 AI applications from more than 100 vendors, covering all body parts, modalities, and disease groups. CARPL's platform eliminates the complexity of multiple vendor integrations by offering a single technical integration point that connects seamlessly with existing PACS and RIS systems. The platform enables healthcare organizations to run AI applications on their own data, perform deep clinical and statistical analysis, and deploy solutions at scale. CARPL's universal AI viewer provides a comprehensive interface for viewing, editing, and annotating AI outputs, supporting multiple formats including probability scores, ROI coordinates, secondary captures, structured reports, and DICOM segmentation. The platform offers both cloud-based and on-premise deployment options, ensuring flexibility and security for diverse clinical environments. CARPL serves radiologists, IT departments, AI developers, and enterprise partners across multiple geographies including the United States, Brazil, Singapore, Australia, and India. The platform features advanced capabilities including automated series identification, intelligent triaging, urgency flagging, report auto-population, and comprehensive AI performance monitoring. With FDA 510(k) clearance and enterprise-grade security, CARPL enables healthcare institutions to accelerate AI adoption while maintaining clinical safety and regulatory compliance.

Company description Carpl.ai official website

Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Carpl.ai?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Brain volumetric analysis
  • Chest X-ray pathologies
  • Fracture detection
  • Mammography cancer detection
  • Musculoskeletal imaging
  • Neurological diseases
  • Osteoarthritis
  • Prostate cancer evaluation
  • Sarcopenia

Who it serves

  • Academic Medical Centers
  • Diagnostic Imaging Centers
  • Health Systems
  • Hospitals
  • Radiology Departments

Deployment & integration

Cloud Saas · Hybrid deployment with recorded integration context.

Recorded integration context: Cerner, Epic, PACS, RIS.

Geographic context

MarketsAustralia · Brazil · India · Singapore · United States
Company sourceOfficial website

Company milestones

Platform expansion

FDA 510(k) clearance obtained, expanded deployment base across 5 countries, marketplace grown to 275+ AI applications from 100+ vendors, multiple case studies published from major healthcare institutions

Partnerships

Recorded partners

  • Einstein Hospital Israelita Brazil
  • FIDI Brazil
  • PACS vendors
  • Synapxe Singapore
  • University Hospitals Cleveland

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

AI Marketplace

Access to 275+ third-party AI applications across 100+ AI vendors for radiology workflows

Platform · Cloud SaaSCompany source

CARPL Enterprise Imaging AI Platform

FDA 510(k) cleared radiology AI orchestration platform with 275+ AI applications from 100+ vendors

Platform · HybridCompany source

Universal AI Viewer

Comprehensive interface for viewing, editing, and annotating any AI output across multiple formats

Software · HybridCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

30% acceleration in MSK x-ray interpretation

University Hospitals Cleveland deployment

Improved emergency department triaging

University Hospitals Cleveland

Improved efficiency of chest x-ray imaging

FIDI Brazil deployment

24/7 AI-powered fracture detection

Einstein Hospital Israelita Brazil

Einstein Hospital Israelita, Brazil

24/7 AI-powered MSK fracture detection through an enterprise-grade AI platform

FIDI, Brazil

Improving efficiency of chest x-ray imaging at Brazil's largest diagnostic imaging center

Synapxe, Singapore

Accelerating AI pilots across Singapore's Public Healthcare System through a Platform Approach

University Hospitals, Cleveland

MSK x-ray interpretation acceleration and emergency department triaging

30% acceleration in MSK x-ray interpretation

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

No active leadership profiles are currently listed.

06 · Company updates

Updates from Carpl.ai

Recent articles published on Carpl.ai's official website.

No Company updates are currently listed.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Medical Imaging & Radiology

Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon